BM-131246 is primarily utilized in research settings, particularly in the field of oncology. It is studied for its potential role in inhibiting specific pathways involved in cancer cell proliferation and survival. Researchers investigate its efficacy in targeting certain receptors or enzymes that are overactive in various types of tumors. Additionally, BM-131246 is explored for its ability to enhance the effectiveness of existing cancer therapies when used in combination treatments. Its application extends to preclinical studies aimed at understanding its pharmacokinetics, safety profile, and mechanism of action, which could pave the way for future therapeutic developments.